Yep I reckon you are right there musoman.
A good portion of their activities a VERY much focussed on problem wound care. The have the size and reach that the TIS needs to capture a good bite of this market. They have amongst the most globally to gain should they align with and market Vitrogro. (even though it may make a bunch of their current products obsolete) Accordingly they also have a lot to lose should it go to a competitor.
Further, on rummaging about on the S@N site there is a lot of the same language used in talking about wound care that TIS use in thier presentations. I was going to copy and past a whole bunch of potential linkages between the two companies but its best if the Tissarians just have a look for them selves
checkit
Snapping
http://global.smith-nephew.com/master/wound_management_1217.htm
- Forums
- ASX - By Stock
- TIS
- world-first $100 million health resrch centre
world-first $100 million health resrch centre, page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)